Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting
- PMID: 17526823
- DOI: 10.2337/dc07-9919
Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting
Abstract
Computer simulation models are mathematical equations combined in a structured framework to represent some real or hypothetical system. One of their uses is to allow the projection of short-term data from clinical trials to evaluate clinical outcomes and costs over a long-term period. This technology is becoming increasingly important to assist decision making in modern medicine in situations where there is a paucity of long-term clinical trial data, as recently acknowledged in the American Diabetes Association Consensus Panel Guidelines for Computer Modeling of Diabetes and its Complications. The Mount Hood Challenge Meetings provide a forum for computer modelers of diabetes to discuss and compare models and identify key areas of future development to advance the field. The Fourth Mount Hood Challenge in 2004 was the first meeting of its kind to ask modelers to perform simulations of outcomes for patients in published clinical trials, allowing comparison against "real life" data. Eight modeling groups participated in the challenge. Each group was given three of the following challenges: to simulate a trial of type 2 diabetes (CARDS [Collaborative Atorvastatin Diabetes Study]); to simulate a trial of type 1 diabetes (DCCT [Diabetes Control and Complications Trial]); and to calculate outcomes for a hypothetical, precisely specified patient (cross-model validation). The results of the models varied from each other and for methodological reasons, in some cases, from the published trial data in important ways. This approach of performing systematic comparisons and validation exercises has enabled the identification of key differences among the models, as well as their possible causes and directions for improvement in the future.
Similar articles
-
Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.Value Health. 2013 Jun;16(4):670-85. doi: 10.1016/j.jval.2013.01.002. Epub 2013 Apr 18. Value Health. 2013. PMID: 23796302
-
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9. Value Health. 2018. PMID: 29909878 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Economic Simulation Modeling in Type 2 Diabetes.Curr Diab Rep. 2020 May 17;20(7):24. doi: 10.1007/s11892-020-01306-y. Curr Diab Rep. 2020. PMID: 32419064 Review.
-
FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 21. Report from the Norwegian Institute of Public Health No. 2017-07. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 21. Report from the Norwegian Institute of Public Health No. 2017-07. PMID: 29553668 Free Books & Documents. Review.
Cited by
-
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes.BMJ Open. 2013 May 28;3(5):e002905. doi: 10.1136/bmjopen-2013-002905. BMJ Open. 2013. PMID: 23793674 Free PMC article.
-
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.CMAJ. 2011 Nov 8;183(16):E1213-20. doi: 10.1503/cmaj.110178. Epub 2011 Oct 3. CMAJ. 2011. PMID: 21969406 Free PMC article.
-
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.Pharmacoeconomics. 2017 Jul;35(7):673-683. doi: 10.1007/s40273-017-0508-2. Pharmacoeconomics. 2017. PMID: 28456972 Review.
-
Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.Osteoporos Int. 2015 May;26(5):1477-89. doi: 10.1007/s00198-014-2999-4. Epub 2015 Jan 8. Osteoporos Int. 2015. PMID: 25567776
-
Adapting and validating diabetes simulation models across settings: accounting for mortality differences using administrative data.J Diabetes Complications. 2013 Jul-Aug;27(4):351-6. doi: 10.1016/j.jdiacomp.2012.12.006. Epub 2013 Jun 13. J Diabetes Complications. 2013. PMID: 23769021 Free PMC article.
